Received Aug 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y019318 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
No symptoms or side effects were reported by HCP.; HCP reporting that a patient received a dose of improperly stored VARIVAX; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 18-JUN-2025, the patient was vaccinated with improperly stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), Injection (lot #Y019318 was valid, expiration date: 21-NOV-2026, 0.5 mL, route of administration and anatomical location were not provided) with sterile diluent (MERCK STERILE DILUENT) for prophylaxis (Product storage error). Temperature excursion of 52.2 F was reported. No symptoms or side effects were reported (No adverse event). No product quality complaint (PQC).